(Press-News.org) November 14, 2023 – IPM South Africa NPC, an affiliate of the Population Council, has been issued a 15-month Transition to Scale Phase 2 award from Grand Challenges Canada to support the market introduction of the dapivirine vaginal ring (DapiRing™) for women in Southern and East Africa.
The DapiRing is a user-controlled vaginal ring that reduces the risk of HIV infection in women during vaginal sex. The ring is made of flexible silicone and can be self-inserted into the vagina for 1 month. In 2020, the DapiRing was endorsed by the European Medicines Agency for use among women aged 18 years or older. In 2021, the DapiRing was recommended by the World Health Organization (WHO) via inclusion in WHO’s HIV guidelines. The DapiRing has received regulatory approvals in South Africa, Zambia, Rwanda, Zimbabwe, Malawi, Uganda, Botswana, Namibia, and Kenya, and is available through national import licenses in Eswatini and Lesotho. As of September 2023, over 113,000 rings have been sold.
The funding from Grand Challenges Canada will support the continued market introduction of the DapiRing. With this funding, IPM South Africa will be able to gather end-user market insights in Rwanda and Botswana by hosting stakeholder education sessions engaging health care providers to refine educational tools and completing the development of end-user materials that resonate with potential users. The tools and resources generated from this award will be tailored to the countries’ local contexts and will be made available to the ministries of health, technical working groups, healthcare providers, and end-users to support choice, leading to greater awareness and uptake of prevention products. Further, the activities conducted with this funding will help build health care provider’s awareness of biomedical HIV prevention, multipurpose prevention technology products, and the competencies needed to prescribe these products.
The DapiRing is one of the key assets acquired by the Population Council from the International Partnership for Microbicides in 2022. The Population Council Center for Biomedical Research and IPM South Africa work together to support activities related to the full lifecycle of product development.
Disclaimer
This is a global website intended for visitors seeking information on the Population Council’s worldwide activities. The information on this website may not comply with the local regulatory requirements of individual countries.
About Grand Challenges Canada
Grand Challenges Canada is dedicated to supporting Bold Ideas with Big Impact®. Funded by the Government of Canada and other partners, Grand Challenges Canada funds innovators in low- and middle-income countries and Canada. The bold ideas Grand Challenges Canada supports integrate science and technology, social and business innovation – known as Integrated Innovation®. Grand Challenges Canada is hosted in Toronto at the Sandra Rotman Centre at the University Health Network. Learn more at https://www.grandchallenges.ca/.
About the Population Council
The Population Council is a leading research organization dedicated to building an equitable and sustainable world that enhances the health and well-being of current and future generations. We generate ideas, produce evidence, and design solutions to improve the lives of underserved populations around the world. Learn more at www.popcouncil.org.
END
Population Council awarded Grand Challenges Canada Grant to support the market introduction of the dapivirine vaginal ring
IPM South Africa has been awarded a 15-month grant to support the large-scale delivery of the dapivirine vaginal ring.
2023-11-17
ELSE PRESS RELEASES FROM THIS DATE:
Air cleaners don’t stop you getting sick, research shows
2023-11-17
Peer reviewed - systematic review - humans
Air filtration systems do not reduce the risk of picking up viral infections, according to new research from the University of East Anglia.
A new study published today reveals that technologies designed to make social interactions safer in indoor spaces are not effective in the real world.
The team studied technologies including air filtration, germicidal lights and ionisers.
They looked at all the available evidence but found little to support hopes that these technologies can make air safe from respiratory or gastrointestinal infections.
Prof Paul Hunter, from UEA’s Norwich Medical ...
From tobacco to alcohol to opioids, Sanford Burnham Prebys researchers are pursuing novel leads and promising therapies to treat addiction
2023-11-17
Addiction is perhaps the most and least visible of public health crises in the United States.
Tens of millions of Americans are addicted to illicit drugs, alcohol, tobacco and other substances including opioids, with both immediate and long-term harm to not just themselves, but also family, friends and society.
At the same time, many of those affected deny or hide their addictions. Most do not seek help. A 2021 national survey on drug use and health by the U.S. Department of Health and Human Services’ Substance Abuse and Mental Health Services Administration (SAMHSA), ...
NCDMPH Director Jeffrey D. Freeman, PhD, MPH to be a keynote speaker at SDMPH Annual Meeting
2023-11-17
Disasters are growing more frequent, severe, and unpredictable, yet our nation lacks a sustainable model for preparedness. Dr. Freeman's presentation will address the advancement of science, practice, and education in the pursuit of a coordinated and scalable approach to preparedness.
To be presented on Day 3 during the Society for Disaster Medicine and Public Health Inc. Annual Meeting which will be held between December 4-6, in Washington, DC. END ...
National analysis shows that 1 in 3000 patients experience cardiac arrest requiring resuscitation during anaesthesia
2023-11-17
A new study ‒ that has examined all cardiac arrests occurring during or soon after surgery in more than 300 UK hospitals over a one-year period ‒ has identified that this extremely dangerous and often fatal event occurs in 3 per 10,000 surgeries requiring anaesthesia.
The study - the 7th National Audit Project of the Royal College of Anaesthetists (NAP7) published in Anaesthesia (the journal of the Association of Anaesthetists) – included data from all NHS hospitals and some in the independent sector and received ...
Cutting-edge research aims to curb fatalities caused by illicit drugs
2023-11-16
University of Technology Sydney (UTS) Centre for Forensic Science PhD candidate Harry Fursman is working on two fronts to prevent harm to people who use drugs: He is testing a new handheld device for rapidly and accurately identifying drug specimens and conducting ongoing chemical analysis of used syringes.
Drugs that are contaminated or substituted with an unexpected substance are a leading cause of death among people who use drugs. In Sydney last week one person died and two people were taken to hospital due to heroin overdoses, after using what ...
Paper offers perspective on future of brain-inspired AI as Python code library passes major milestone
2023-11-16
Four years ago, UC Santa Cruz’s Jason Eshraghian developed a Python library that combines neuroscience with artificial intelligence to create spiking neural networks, a machine learning method that takes inspiration from the brain’s ability to efficiently process data. Now, his open source code library, called “snnTorch,” has surpassed 100,000 downloads and is used in a wide variety of projects, from NASA satellite tracking efforts to semiconductor companies optimizing chips for AI.
A new paper published in the journal Proceedings of the IEEE documents the coding ...
Winners of Applied Microbiology International Horizon Awards are announced
2023-11-16
The winners of the Applied Microbiology International Horizon Awards were announced at the prestigious Environmental Microbiology lecture 2023, held at BMA House in London on November 16.
The prizes, awarded by Applied Microbiology International, celebrate the brightest minds in the field and promote the research, group, projects, products and individuals who continue to help shape the future of applied microbiology.
Dr Christopher Stewart of Newcastle University in the UK was named as this year’s winner of the WH Pierce Prize, which is presented to a scientist who has used microbiology to make a significant contribution to One Health advancements.
The primary ...
Highlights from the journal CHEST®, November 2023
2023-11-16
Glenview, Illinois – Published monthly, the journal CHEST® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.
The November issue of the CHEST journal contains 48 articles, including clinically relevant research, reviews, case series, commentary and more. Each month, the journal also offers complementary resources, including visual ...
Three-pronged approach discerns qualities of quantum spin liquids
2023-11-16
In 1973, physicist Phil Anderson hypothesized that the quantum spin liquid, or QSL, state existed on some triangular lattices, but he lacked the tools to delve deeper. Fifty years later, a team led by researchers associated with the Quantum Science Center headquartered at the Department of Energy’s Oak Ridge National Laboratory has confirmed the presence of QSL behavior in a new material with this structure, KYbSe2.
QSLs — an unusual state of matter controlled by interactions among entangled, or intrinsically linked, magnetic atoms called spins — excel at stabilizing quantum mechanical activity in KYbSe2 and other delafossites. These materials are prized for ...
Cancer therapy shows promise against tuberculosis
2023-11-16
A promising new cancer therapy also appears extremely potent against one of the world’s most devastating infectious diseases: tuberculosis (TB).
Scientists at Texas Biomedical Research Institute (Texas Biomed) found the therapy dramatically reduces TB growth, even for bacteria that are drug-resistant. The findings, reported in the journal Biomedicine & Pharmacotherapy, were made in novel cellular models featuring TB-infected human cells that can help accelerate screening of potential TB drugs and therapies like this one.
The therapy evaluated in this study combines two ...
LAST 30 PRESS RELEASES:
Study unexpectedly finds living in rural, rather than urban environments in first five years of life could be a risk factor for developing type 1 diabetes
Editorial urges deeper focus on heart-lung interactions in pulmonary vascular disease
Five University of Tennessee faculty receive Fulbright Awards
5 advances to protect water sources, availability
OU Scholar awarded Fulbright for Soviet cinema research
Brain might become target of new type 1 diabetes treatments
‘Shore Wars:’ New research aims to resolve coastal conflict between oysters and mangroves, aiding restoration efforts
Why do symptoms linger in some people after an infection? A conversation on post-acute infection syndromes
Study reveals hidden drivers of asthma flare-ups in children
Physicists decode mysterious membrane behavior
New insights about brain receptor may pave way for next-gen mental health drugs
Melanoma ‘sat-nav’ discovery could help curb metastasis
When immune commanders misfire: new insights into rheumatoid arthritis inflammation
SFU researchers develop a new tool that brings blender-like lighting control to any photograph
Pups in tow, Yellowstone-area wolves trek long distances to stay near prey
AI breakthrough unlocks 'new' materials to replace lithium-ion batteries
Making molecules make sense: A regional explanation method reveals structure–property relationships
Partisan hostility, not just policy, drives U.S. protests
The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: August 1, 2025
Young human blood serum factors show potential to rejuvenate skin through bone marrow
Large language models reshape the future of task planning
Narrower coverage of MS drugs tied to higher relapse risk
Researchers harness AI-powered protein design to enhance T-cell based immunotherapies
Smartphone engagement during school hours among US youths
Online reviews of health care facilities
MS may begin far earlier than previously thought
New AI tool learns to read medical images with far less data
Announcing XPRIZE Healthspan as Tier 5 Sponsor of ARDD 2025
Announcing Immortal Dragons as Tier 4 Sponsor of ARDD 2025
Reporting guideline for chatbot health advice studies
[Press-News.org] Population Council awarded Grand Challenges Canada Grant to support the market introduction of the dapivirine vaginal ringIPM South Africa has been awarded a 15-month grant to support the large-scale delivery of the dapivirine vaginal ring.